Login

Register

• 
  • 
  • Current Issue
  • Archive
  • Patient Guides
  • Subscription
• 
  • 
  • Blogs
  • Message Board
  • Calendar
• 
  • 
  • Diagnosis
  • Before Treatment
  • During Treatment
  • End of Treatment
  • Survivorship
  • Metastatic & Chronic Cancer
  • Caregivers & Co-Survivors
  • Risk & Prevention
• 
  • 
  • Brain
  • Breast
  • Childhood
  • Colorectal
  • Head and Neck
  • Leukemia
  • Lung
  • Lymphoma
  • Ovarian
  • Prostate
  • Skin
  • Other Cancer Types
• 
• 

CURE COMMUNITY

CATEGORIES [ SABCS2011, BREAST CANCER ]

Video blog: HER2-targeted agents

BY DEBU TRIPATHY | DECEMBER 10, 2011

Dr. Debu Tripathy explains the HER2 pathway's involvement in breast cancer and how new investigational drugs, including pertuzumab and TDM1, as well as combinations of new and approved drugs are targeting this pathway.

RELATED POSTS

• My beauty marks
• The search for the 2013 Pink Power Moms has begun!
• Why insensitive remarks after Jolie's prophylactic surgery can be a good thing
• Why me?
• Is "triple-negative breast cancer" merely a descriptive term?

SHARE

FACEBOOK | TWITTER | EMAIL

VIEW

COMMENTS (0) | PRINT | SUBSCRIBE

COMMENTS

There are no comments for this entry.

ADD A COMMENT

Your comment will appear once approved by CURE staff:
* Required fields

NAME*:

EMAIL (will not be published)*:

COMMENT*:

Enter text that you see in the image (text is CASE-SENSITIVE)*:

   

SEARCH BLOGS

BROWSE BY AUTHOR

Select an Author... Debu Tripathy Kathy LaTour Elizabeth Whittington Melissa Weber Lena Huang Lacey Meyer Susan McClure Katherine Lagomarsino Suzanne Lindley Guest Lindsay Ray Jon Garinn

BROWSE BY CATEGORY

Select a Category... ASCO ASCO2010 ASCO2011 Blood cancers Breast cancer Caregiving Childhood cancers Colorectal cancer Diagnosis Exercise Featured Gastric cancer General Gynecological cancers Lung cancer News Nutrition Prostate cancer Reviews SABCS2010 SABCS2011 SABCS2012 Skin cancer Survivorship Treatment Young adults

AUTHOR BIOS

• View all blog authors

RECENT POSTS

• ASCO kicks off with promising immunotherapy studies
• Men’s fitness protects against common cancers – and mortality
• Less is more in radiation for lung cancer
• My beauty marks
• Genetics, genomics and biomarkers…oh my!

MOST POPULAR

• Finally, good news for triple negative breast cancer patients!
• Would you date a cancer survivor?
• New exercise guidelines for cancer survivors
• PARP inhibitors create buzz at ASCO
• Tips for managing the financial cost of caregiving

CURE Media Group About Us | Contact Us | CMG Corporate | Cancer Continuum | Press | FAQs | Write for CURE

Advertise Media Kit | Reprints

Manage Subscription Services | Newsletters | Join the CURE Survey Panel | My Account

Legal Licensing | Terms of Use | Privacy Policy

© 2013 CURE Media Group. All rights reserved. Sitemap

CURE does not provide medical, diagnostic, or treatment advice.